ACTRN12605000762651尚未招募不适用
Optimising glycaemic control in paediatric patients on insulin pump therapy: impact of glycaemic load and bolus wave type on postprandial glycaemia
Royal Children's Hospital, Parkville, Vic 3052.0 个研究点目标入组 36 人开始时间: 2005年11月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 6 Years 至 12 Years（—）
- 性别
- All
入选标准
- •Prepubertal children specifically targeted to eliminate potential confounding effects of counter-regulatory hormones of puberty.2. Type 1 diabetes > 1 year duration; active patients of RCH diabetes clinic3. Established use of insulin pump therapy (using short acting analog insulin) for > 3 months4. Insulin pump with incorporated meal bolus calculator device (capable of delivering both single and dual wave boluses)5. HbA1C < 8.6% HbA1C empirically chosen as cut-off for 'acceptable' baseline glycaemic control - corresponds to the mean HbA1C for all paediatric centres participating in the international Hvidore diabetes study group
排除标准
- •1. Non-English speaking2. Diagnosed eating disorder3. Concomitant dietary restriction (eg food allergy)4. Use of any other medication that may lower blood glucose5. Free of diabetes-related complications (microvascular disease, hypothyroidism, coeliac disease).
研究者
相似试验
进行中（未招募）
不适用
The Control of Hyperglycaemia In Paediatric intensive care (The CHIP Trial). - The CHIP TrialEUCTR2006-005715-10-GBRoyal Brompton & Harefield NHS Trust1,500
已完成
不适用
Control of hyperglycaemia in paediatric intensive careHyperglycaemiaSigns and SymptomsElevated blood glucose levelISRCTN61735247Royal Brompton & Harefiled NHS Trust (UK)1,500
进行中（未招募）
不适用
Optimizing of blood sugar control for surgical patients with diabetes type 2.Diabetes type 2.MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2013-002936-26-DKChristoffer Hedetoft
招募中
不适用
Glycaemic control in patients with type 2 diabetes and colorectal- or breast cancer treated with curative intentType 2 diabetes (T2DM)Breast cancer/borstkankerColorectal cancer/colorectale kankerHypertension/hypertensieDyslipidemia/dyslipidemieNL-OMON23282Diabetes Kenniscentrum Zwolle156
已完成
4 期
To study the impact of age-patient-related, treatment-related, behavior and structure of care-related variables on glycemic control and quality of life in children, adolescents and young adults with type-1 diabetes mellitusCTRI/2012/08/002925Sanofi Synthelabo India Limited5,000